MALARIA DETECTION BY QBC

Bacterial/ Viral

Report in 48Hrs

At Home

No Fasting Required

Details

Rapid malaria detection by Quantitative Buffy Coat.

₹414₹592

30% OFF

Malaria Detection by QBC - Comprehensive Medical Test Guide

Why is it done?
- QBC (Quantitative Buffy Coat) is a rapid diagnostic method that detects and identifies Plasmodium parasites in blood samples to confirm malaria infection
- Primary indication: Diagnosis of malaria in patients presenting with fever, chills, and sweating, particularly in endemic regions or those with recent travel history
- Used for detection of all four human malaria parasites: Plasmodium falciparum, P. vivax, P. ovale, and P. malariae
- Performed when clinical symptoms suggest malaria or as follow-up to initial screening
- Useful for monitoring treatment efficacy and detecting parasitemia recurrence during follow-up
- Typically ordered urgently in acute fever cases with malaria suspicion, especially in high-transmission areas
Normal Range
- Negative Result: No Plasmodium parasites detected in the blood sample - indicates absence of malaria infection
- Positive Result: Plasmodium parasites detected - indicates active malaria infection with identification of species
- Quantitative Values: Measured as parasites per microliter (µL) of blood; ranges typically from <1 to >200,000 parasites/µL depending on infection severity
- Reference Value: Negative or <1 parasite/µL is considered normal
- Parasitemia Levels: Low (<1,000/µL), Moderate (1,000-100,000/µL), High (>100,000/µL) - correlates with disease severity
- Species Identification: QBC identifies specific Plasmodium species through characteristic fluorescent patterns and morphology under fluorescence microscopy
Interpretation
- Negative Result Interpretation: Malaria parasites are not present in the blood at detectable levels; however, early infections (pre-patent period) may show negative results; repeat testing may be needed if clinical suspicion remains high
- Positive P. falciparum: Most severe form; displays as multiple rings; high parasitemia often correlates with severe malaria and cerebral involvement; requires immediate antimalarial treatment
- Positive P. vivax: Shows infected RBCs with Schüffner's stippling; generally lower parasitemia; causes tertian fever pattern; risk of relapse due to hypnozoites
- Positive P. ovale: Similar clinical presentation to P. vivax; displays oval-shaped RBCs; also has hypnozoite stage; requires primaquine for complete cure
- Positive P. malariae: Quartan fever pattern (fever every 72 hours); typically low parasitemia; usually less severe but may cause chronic infections
- High Parasitemia (>100,000/µL): Indicates severe malaria with risk of complications including cerebral malaria, acute renal failure, and severe anemia; requires ICU monitoring
- Mixed Species Infections: Can occur and require identification of all species for appropriate treatment selection
- Factors Affecting Results: Timing of collection (parasitemia is cyclical and may fluctuate), partial treatment prior to testing, low parasite density in early infection, operator experience with microscopy
Associated Organs
- Primary Organ Systems: Blood and circulatory system (parasites infect RBCs); liver (primary replication site); brain (risk of cerebral malaria); kidneys (acute kidney injury); lungs (acute respiratory distress syndrome)
- Hepatomegaly: Liver enlargement common in malaria; indicates parasitic sequestration and inflammation
- Splenomegaly: Spleen enlargement from phagocytosis of infected RBCs and immune response activation
- Cerebral Malaria: Life-threatening complication involving brain; causes altered consciousness, seizures, coma; associated with high parasitemia and P. falciparum
- Acute Kidney Injury: Common complication of severe malaria; results from reduced renal perfusion and direct parasitic effects
- Severe Anemia: Results from destruction of infected RBCs; exacerbated in chronic infections; may require transfusion
- Acute Respiratory Distress Syndrome (ARDS): Severe pulmonary complication; increased pulmonary capillary permeability; associated with high mortality
- Metabolic Acidosis: Indicates severe malaria; results from tissue hypoxia and lactate accumulation
Follow-up Tests
- Repeat QBC Testing: Performed every 48 hours during treatment to monitor parasite clearance; negative result after 3 consecutive days indicates adequate response
- Thick and Thin Blood Smear: Traditional confirmatory test; provides morphological detail; useful for quantifying parasitemia and identifying species
- Rapid Diagnostic Tests (RDTs): Immunochromatographic tests for rapid confirmation; detects parasite antigens; results in 15-20 minutes
- PCR (Polymerase Chain Reaction): Gold standard for species identification and detection of low parasitemia; molecular confirmation for ambiguous cases
- Complete Blood Count (CBC): Assess hemoglobin (for anemia), platelets (thrombocytopenia common), and WBC; monitor for complications
- Liver Function Tests (LFTs): AST, ALT, bilirubin to assess hepatic involvement and drug toxicity; baseline before treatment initiation
- Renal Function Tests: Creatinine and BUN to monitor for acute kidney injury; assess glomerular filtration rate
- Electrolytes and Glucose: Monitor for metabolic derangements; hypoglycemia common in severe malaria; assess acid-base status
- Coagulation Studies: PT/INR, PTT in severe cases to assess for disseminated intravascular coagulation (DIC)
- Chest X-ray: Evaluate for pulmonary complications including ARDS, pulmonary edema if respiratory symptoms present
- Lumbar Puncture (CSF Analysis): Performed if cerebral malaria suspected to rule out bacterial meningitis; CSF should be parasite-negative in malaria
Fasting Required?
- Fasting Requirement: NO - Fasting is not required for Malaria Detection by QBC
- Blood Sample Collection: Can be obtained at any time of day; no dietary restrictions necessary
- Optimal Timing: Ideally collected during fever spike when parasitemia is highest; if initial test negative with high clinical suspicion, repeat sampling 12-24 hours later recommended
- Medications to Continue: No medications need to be held; antimalarial drugs can be continued if already initiated
- Patient Preparation: No special preparation needed; patient can eat and drink normally
- Sample Type: Venous blood (3-5 mL) collected in EDTA anticoagulant tube (purple top)
- Sample Handling: Should be processed promptly; ideally within 2-4 hours of collection; keep at room temperature; prolonged storage may reduce parasite visibility

How our test process works!